Search Results - "Kosmider, B"

Refine Results
  1. 1

    Trolox contributes to Nrf2-mediated protection of human and murine primary alveolar type II cells from injury by cigarette smoke by Messier, E M, Bahmed, K, Tuder, R M, Chu, H W, Bowler, R P, Kosmider, B

    Published in Cell death & disease (01-04-2013)
    “…Cigarette smoke (CS) is a main risk factor for chronic obstructive pulmonary disease (COPD). Oxidative stress induced by CS causes DNA and lung damage…”
    Get full text
    Journal Article
  2. 2

    Comparison between the genotoxicity of cis-Pt(II) complex of 3-aminoflavone and cis-DDP in lymphocytes evaluated by the comet assay by KOSMIDER, B, OSIECKA, R, ZYNER, E, OCHOCKI, J

    “…cis-bis(3-aminoflavone)dichloroplatinum(II) [cis-Pt(II) complex of 3-aminoflavone] is an analog of cis-DDP characterized by low cytotoxicity and anticancer…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    A73 BEYOND CIGARETTE SMOKE IN COPD: Dna Damage In Human Alveolar Type Ii Cells In Emphysema by Kosmider, B, Vlasenko, L, Boukhenouna, S, Tan, L, Marchetti, N, Bolla, S, Mandapati, C, Xander, N, Kelsen, S, Criner, G J, Bahmed, K

    “…Results Our data indicates high oxidative stress in human ATII cells induced by cigarette smoke extract in vitro as measured by 4-HNE staining by…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Flavonoid compounds: a review of anticancer properties and interactions with cis-diamminedichloroplatinum(II) by Kosmider, Beata, Osiecka, Regina

    Published in Drug development research (01-12-2004)
    “…Flavonoid compounds, especially quercetin and genistein, have antitumor activity. These compounds are cytotoxic to cancer cells but have no or insignificant…”
    Get full text
    Journal Article
  9. 9

    Induction of apoptosis and necrosis in A549 cells by the cis-Pt(II) complex of 3-aminoflavone in comparison with cis-DDP by Kosmider, Beata, Zyner, Elzbieta, Osiecka, Regina, Ochocki, Justyn

    Published in Mutation research (12-09-2004)
    “…Non-small cell lung cancer (NSCLC) includes a group of tumors that respond poorly to drugs. cis-Diamminedichloroplatinum(II) ( cis-DDP) toxicity still remains…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Nonpeptidic Inhibitors of Human Leukocyte Elastase. 6. Design of a Potent, Intratracheally Active, Pyridone-Based Trifluoromethyl Ketone by Bernstein, Peter R, Gomes, Bruce C, Kosmider, Benedict J, Vacek, Edward P, Williams, Joseph C

    Published in Journal of medicinal chemistry (01-01-1995)
    “…Further modification of the 3-amino substituent in a trifluoromethyl ketone-based series of 3-amino-6-phenylpyridin-2-ones that had been optimized for oral…”
    Get full text
    Journal Article
  12. 12
  13. 13

    The involvement of non-B DNA structures in gross chromosomal rearrangements by Bacolla, Albino, Wojciechowska, Marzena, Kosmider, Beata, Larson, Jacquelynn E., Wells, Robert D.

    Published in DNA repair (08-09-2006)
    “…Non-B DNA conformations adopted by certain types of DNA sequences promote genetic instabilities, especially gross rearrangements including translocations. We…”
    Get full text
    Journal Article
  14. 14

    Electrochemical genosensing of the interaction between the potential chemotherapeutic agent, cis-bis(3-aminoflavone)dichloroplatinum(II) and DNA in comparison with cis-DDP by Erdem, Arzum, Kosmider, Beata, Osiecka, Regina, Zyner, Elzbieta, Ochocki, Justyn, Ozsoz, Mehmet

    “…The interaction of cis-diamminedichloroplatinum(II) ( cis-DDP) and the potential novel chemotherapeutic agent, cis-bis(3-aminoflavone)dichloroplatinum(II) (…”
    Get full text
    Journal Article
  15. 15

    RG 12561 (dalvastatin): a novel synthetic inhibitor of HMG-CoA reductase and cholesterol-lowering agent by Amin, D, Gustafson, S K, Weinacht, J M, Cornell, S A, Neuenschwander, K, Kosmider, B, Scotese, A C, Regan, J R, Perrone, M H

    Published in Pharmacology (1993)
    “…RG 12561 (dalvastatin) is a prodrug which converts to its open hydroxyacid form in the body. The Na salt of RG 12561 (RG 12561-Na) is a potent inhibitor of…”
    Get more information
    Journal Article
  16. 16

    Fragile X repeats are potent inducers of complex, multiple site rearrangements in flanking sequences in Escherichia coli by Kosmider, Beata, Wells, Robert D.

    Published in DNA repair (01-12-2007)
    “…(CGG·CCG) n repeats induce the formation of complex, multiple site rearrangements and/or gross deletions in flanking DNA sequences in Escherichia coli…”
    Get full text
    Journal Article
  17. 17

    Induction of apoptosis and necrosis in lymphocytes by the cis-Pt(II) complex of 3-aminoflavone in comparison with cis-DDP by Kosmider, Beata, Osiecka, Regina, Ciesielska, Ewa, Szmigiero, Leszek, Zyner, Elzbieta, Ochocki, Justyn

    Published in Mutation research (14-03-2004)
    “…cis-Diamminedichloroplatinum(II) ( cis-DDP) is one of the most widely administrated antitumor drugs. However, the use of cis-DDP is severely limited because of…”
    Get full text
    Journal Article
  18. 18

    Evaluation of the genotoxicity of cis-bis(3-aminoflavone)dichloroplatinum(II) in comparison with cis-DDP by Kosmider, Beata, Wyszynska, Kalina, Janik-Spiechowicz, Ewa, Osiecka, Regina, Zyner, Elzbieta, Ochocki, Justyn, Ciesielska, Ewa, Wasowicz, Wojciech

    Published in Mutation research (14-03-2004)
    “…Short-term tests that detect genetic damage have provided information needed for evaluating carcinogenic risks of chemicals to man. The mutagenicity of…”
    Get full text
    Journal Article
  19. 19

    Enhanced P53 and BAX gene expression and apoptosis in A549 cells by cis-Pt(II) complex of 3-aminoflavone in comparison with cis-DDP by Kosmider, Beata, Wojcik, Izabela, Osiecka, Regina, Bartkowiak, Jacek, Zyner, Elzbieta, Ochocki, Justyn, Liberski, Pawel

    Published in Investigational new drugs (01-08-2005)
    “…Lung cancer remains one of the most common causes of cancer-related death worldwide. Approximately 80% is histologically non-small cell lung carcinoma (NSCLC)…”
    Get full text
    Journal Article
  20. 20